Tunghai University Institutional Repository:Item 310901/26237
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 21921/27947 (78%)
Visitors : 4250649      Online Users : 415
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://140.128.103.80:8080/handle/310901/26237


    Title: 海峽兩岸原料藥設備互補整合可行性探討─以 Y和S公司為例
    Other Titles: The study of Reciprocal integration of API(Active Pharmaceutical Ingredients) equpment-A case study of Y company and S companyacross the Taiwan Strait
    Authors: 梁榮樹
    LIANG, JUNG-SHU
    Contributors: 詹家昌
    CHAN CHIA CHANG
    高階經營管理碩士在職專班
    Keywords: 水平整合;搪玻璃設備;原料藥設備;互補性整合
    the level of integration;glass-lined equipment;API( Active Pharmaceutical Ingredients)Equipment;the integration of complementary
    Date: 2015
    Issue Date: 2015-12-22T03:29:42Z (UTC)
    Abstract: 原料藥設備在台灣市場規模太小而且有很多因為原物料和技術的取得較歐美日困難,大部分必須依賴進口,有生產的也因為經濟規模太小,以台灣為基本市場外必須依賴外銷,且又要面對中國大陸及其它競爭。本研究探討原料藥生產設備,如何在符合法規下,選用較經濟的設備,和大陸水平整合及互補形成供應鏈,如何面對歐、美、日的技術和高水平製造工藝在技術上取得突破,和在價格優勢及符合法規下取得廠商的信賴和使用。本研究探討原料藥生產,在設備上的選擇需在符合法規的規定下,選用設備,如何在可以通過認證及競爭下,選用最適化的設備,並研究台灣的原料藥廠在取得歐美的認證如何和大陸藥廠在取得歐美認證的競爭下取得優勢。本研究以台灣原料藥廠Y公司和S公司設廠,使用台灣和大陸的設備整合和使用台灣及歐美日的設備整合,不同的規畫為例,探討在符合法規的認證及考慮到投資成本下如何選用最適當的設備。一、 原料藥廠在研發及製程放大的階段需同時考慮到設備的實用性和互補性。二、 成本的考量需在符合法規及符合環保的基礎上進行。三、 台灣和大陸的原料藥設備水平整合及互補性整合更有競爭優勢。四、 以海峽兩岸原料藥設備應用到特化業並推廣至亞洲及佈局全世界。
    The model of material medical equipment is too small in Taiwan. We need to rely on importation because of our material is not enough and acquirement is difficult. Taiwan must rely on the basic market but for export and we have to face competition in China and India.The study is to discuss about in pharmaceutical raw materials equipment how to choose much more economic equipment and certified Horizontal integration and complementary supply chain formation with China how to deal with a high level of technology and manufacturing processes in Europe America and Japan acquire breakthrough between price advantage and get the company's trust and use comply with law.The study is to investigate in pharmaceutical raw materials equipment, how to choose equipment comply with law, how to pass the certification and competitive to select the most suitable equipment and study for pharmaceutical raw materials company in Taiwan to obtain the certification with European and America. And China's pharmaceutical companies to obtain certification competitive advantage in Europe.In this study, The pharmaceutical raw materials company of Taiwan Y and S company as an example to discuss certification in compliance with laws and regulations and consider about how to choose the most appropriate equipment under the investment costs. 1.Pharmaceutical raw materials in research and the stage of process need to enlarge we should consider about the equipment of practicality and complementary.2.Our cost should be based on the environmental laws and conform with laws and regulations.3. The pharmaceutical raw materials equipment should be horizontal integration and complementary integration in Taiwan and China, and it will enhance the competitive power.4.In across the Taiwan Straits the pharmaceutical raw materials equipment applications to specialized industry and popularize to Asia and throughout the whole world.
    Appears in Collections:[Executive Master of Business Administration ] Master's Theses

    Files in This Item:

    File SizeFormat
    103THU01026051-001.pdf1382KbAdobe PDF105View/Open


    All items in THUIR are protected by copyright, with all rights reserved.


    本網站之東海大學機構典藏數位內容,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback